<meta name="summary-card" content="True">
<div class="table-container">
  <table id="Pharm" class="table5 row1-center">
    <thead>
      <tr>
        <th>Drug</th>
        <th>Class</th>
        <th>Indication</th>
        <th>ADRs</th>
        <th>Notes</th>
      </tr>
    </thead>
    <tbody>
        <tr  id="section-mAb"><td class="row-divider"colspan="4">Antibodies</td></tr>
      <tr>
        <td>Alemtuzumab</td>
        <td>anti-CD52 mAb</td>
        <td>CLL, MS</td>
        <td>“52 cards in a deck → drink Ale”</td>
      </tr>
      <tr>
        <td>Bevacizumab</td>
        <td>anti-VEGF mAb</td>
        <td>Metastatic CRC, NSCLC, RCC</td>
        <td>“Vacuum packing vegetables down your butt”</td>
      </tr>
      <tr>
        <td>Cetuximab</td>
        <td>anti-EGFR mAb</td>
        <td>Colon and head & neck cancers</td>
        <td>“CET = <u>C</u>olon, <u>E</u>GFR, <u>T</u>hroat”</td>
      </tr>
      <tr>
        <td>Rituximab</td>
        <td>anti-CD20 mAb</td>
        <td>Non-Hodgkin lymphoma, CLL</td>
        <td>“NHL <u>20</u> cover = guy in <u>TUX</u>edo</td>
      </tr>
      <tr>
        <td>Trastuzumab</td>
        <td>anti-HER2 mAb</td>
        <td>HER2+ breast cancer</td>
        <td>“Tras-2-zumab → Hurts you”</td>
      </tr>
      <tr>
        <td>Infliximab</td>
        <td>anti-TNF-α mAb</td>
        <td>Autoimmune diseases (RA, Crohn's, UC)</td>
        <td>“INFLIX damage during inflammation”</td>
      </tr>
      <tr>
        <td>Daclizumab</td>
        <td>anti-CD25 mAb</td>
        <td>Multiple sclerosis</td>
        <td>“#25 Ben Simmons MONSTER SMASH (DAC)”</td>
      </tr>
      <tr>
        <td>Eculizumab</td>
        <td>anti-C5 complement mAb</td>
        <td>Paroxysmal nocturnal hemoglobinuria</td>
        <td>“E-cul car w/ Pretty Nice Head”</td>
      </tr>
      <tr>
        <td>Natalizumab</td>
        <td>anti-α4-integrin mAb</td>
        <td>MS, Crohn’s</td>
        <td>“TAILs & 4 legs → Multiple Species”</td>
      </tr>
      <tr>
        <td>Ustekinumab</td>
        <td>anti–IL-12/IL-23 mAb</td>
        <td>Psoriasis</td>
        <td>“Used to be 12, now 23”</td>
      </tr>
      <tr>
        <td>Abciximab</td>
        <td>anti–GPIIb/IIIa mAb</td>
        <td>Antiplatelet (PCI)</td>
        <td>“ABC = IIb/IIIa = 2×3 = 6”</td>
      </tr>
      <tr>
        <td>Denosumab</td>
        <td>anti-RANKL mAb</td>
        <td>Osteoporosis</td>
        <td>"<u>Deno</u> socks on your r<u>ANK</u>Le”</td>
      </tr>
      <tr>
        <td>Omalizumab</td>
        <td>anti-IgE mAb</td>
        <td>Allergic asthma</td>
        <td>“Ig8 = #18 = Peyton Manning = Omaha”</td>
      </tr>
      <tr>
        <td>Palivizumab</td>
        <td>anti–RSV F protein mAb</td>
        <td>RSV prophylaxis</td>
        <td>“Pali-o diet → <u>R</u>eally <u>S</u>imple <u>V</u>egetarians”</td>
      </tr>
      <tr>
        <td>Tocilizumab</td>
        <td>anti–IL-6 receptor mAb</td>
        <td>RA, cytokine release syndrome</td>
        <td>“Silly 6 yr olds”</td>
      </tr>
      <tr id="section-misc-biologics"><td class="row-divider" colspan="5">Biologics & Fusion Proteins</td></tr>
      <tr>
        <td>Abatacept</td>
        <td>CD80/86 fusion protein</td>
        <td>RA, autoimmune conditions</td>
        <td>—</td>
        <td>“aBaTacept intercepts B-cell activation by T-cells”</td>
      </tr>
      <tr>
        <td>Vemu<u>raf</u>enib<br>Dab<u>raf</u>enib<br>Enco<u>raf</u>enib</td>
        <td><u>BRAF</u> V600E kinase inhibitors</td>
        <td>Late-stage melanoma (BRAF V600E+)</td>
        <td>—</td>
        <td>“vemuRAFenib”</td>
      </tr>
      <tr>
        <td>Palbociclib</td>
        <td>CDK4/6 inhibitor</td>
        <td>Metastatic breast cancer</td>
        <td>—</td>
        <td>“Pablo rode his biCYCLE from 4-6 most (mets) days”</td>
      <tr id="section"><td class="row-divider" colspan="5">Antibiotics</td></tr>
      <tr><td class="row-subdivider" colspan="5">Cell Wall</td></tr>
      <tr>
        <td>Cefazolin</td>
        <td>1st gen Cephalosporin</td>
        <td>Surgical prophylaxis</td>
        <td>Hypersensitivity</td>
        <td></td>
      </tr>
      <tr>
        <td>Cefuroxime</td>
        <td>2nd gen Cephalosporins</td>
        <td>Gram-negative infections</td>
        <td>Disulfiram rxn (cefotetan)</td>
        <td></td>
      </tr>
      <tr>
        <td>Cefotetan</td>
        <td>2nd gen Cephalosporins</td>
        <td>Gram-negative infections</td>
        <td>Disulfiram rxn (cefotetan)</td>
        <td></td>
      </tr>
      <tr>
        <td>Cefoxitin</td>
        <td>2nd gen Cephalosporins</td>
        <td>Gram-negative infections</td>
        <td>Disulfiram rxn (cefotetan)</td>
        <td></td>
      </tr>
      <tr>
        <td>Cefotaxime</td>
        <td>3rd gen Cephalosporins</td>
        <td>Severe Gram– infections</td>
        <td>Hypersensitivity</td>
        <td></td>
      </tr>
      <tr>
        <td>Ceftazidime</td>
        <td>3rd gen Cephalosporins</td>
        <td>Severe Gram– infections</td>
        <td>Hypersensitivity</td>
        <td></td>
      </tr>
      <tr>
        <td>Cefepime</td>
        <td>4th gen Cephalosporin</td>
        <td>Pseudomonas, broad Gram– coverage</td>
        <td>Seizures (high dose)</td>
        <td></td>
      </tr>
      <tr>
        <td>Clavulanate</td>
        <td>Beta-lactamase inhibitors</td>
        <td>Combined with penicillins</td>
        <td>GI upset</td>
        <td></td>
      </tr>
      <tr>
        <td>Tazobactam</td>
        <td>Beta-lactamase inhibitors</td>
        <td>Combined with penicillins</td>
        <td>GI upset</td>
        <td></td>
      </tr>
      <tr>
        <td>Sulbactam</td>
        <td>Beta-lactamase inhibitors</td>
        <td>Combined with penicillins</td>
        <td>GI upset</td>
        <td></td>
      </tr>
      <tr>
        <td>Bacitracin</td>
        <td>Cell wall inhibitor</td>
        <td>Topical Gram+ skin infections</td>
        <td>Nephrotoxicity (if systemic)</td>
        <td></td>
      </tr>
      <tr>
        <td>Oxacillin</td>
        <td>Penicillinase-resistant Penicillins</td>
        <td>Staphylococcus aureus (non-MRSA)</td>
        <td>Interstitial nephritis</td>
        <td></td>
      </tr>
      <tr>
        <td>Nafcillin</td>
        <td>Penicillinase-resistant Penicillins</td>
        <td>Staphylococcus aureus (non-MRSA)</td>
        <td>Interstitial nephritis</td>
        <td></td>
      </tr>
      <tr>
        <td>Amoxicillin</td>
        <td>Aminopenicillins</td>
        <td>Broad-spectrum (HELPSS organisms)</td>
        <td>Rash with EBV, diarrhea</td>
        <td></td>
      </tr>
      <tr>
        <td>Ampicillin</td>
        <td>Aminopenicillins</td>
        <td>Broad-spectrum (HELPSS organisms)</td>
        <td>Rash with EBV, diarrhea</td>
        <td></td>
      </tr>
      <tr>
        <td>Piperacillin / Ticarcillin</td>
        <td>Antipseudomonal Penicillins</td>
        <td>Pseudomonas, Gram– rods</td>
        <td>Same as penicillin</td>
        <td></td>
      </tr>
      <tr>
        <td>Aztreonam</td>
        <td>Monobactam</td>
        <td>Gram– rods only</td>
        <td>Generally safe</td>
        <td></td>
      </tr>
      <tr>
        <td>Daptomycin</td>
        <td>Lipopeptide</td>
        <td>MRSA, VRE</td>
        <td>Myopathy, CPK elevation</td>
        <td></td>
      </tr>
      <tr>
        <td>Penicillin</td>
        <td>Beta-lactam</td>
        <td>Gram-positive infections</td>
        <td>Allergic reactions</td>
        <td></td>
      </tr>
      <tr>
        <td>Cephalexin / Ceftriaxone</td>
        <td>Cephalosporins</td>
        <td>Broad spectrum</td>
        <td>Hypersensitivity</td>
        <td></td>
      </tr>
      <tr>
        <td>Carbapenems</td>
        <td>Beta-lactam</td>
        <td>Serious infections</td>
        <td>Seizures (rare)</td>
        <td></td>
      </tr>
      <tr>
        <td>Vancomycin</td>
        <td>Glycopeptide</td>
        <td>MRSA</td>
        <td>Red man syndrome</td>
        <td></td>
      </tr>
      <tr><td class="row-subdivider" colspan="5">Protein Synthesis</td></tr>
      <tr>
        <td>Tobramycin</td>
        <td>Aminoglycosides</td>
        <td>Gram– rods, bowel prep</td>
        <td>Ototoxicity, nephrotoxicity</td>
        <td></td>
      </tr>
      <tr>
        <td>Neomycin</td>
        <td>Aminoglycosides</td>
        <td>Gram– rods, bowel prep</td>
        <td>Ototoxicity, nephrotoxicity</td>
        <td></td>
      </tr>
      <tr>
        <td>Erythromycin</td>
        <td>Macrolides</td>
        <td>Respiratory infections, MAC</td>
        <td>QT prolongation, GI upset</td>
        <td></td>
      </tr>
      <tr>
        <td>Clarithromycin</td>
        <td>Macrolides</td>
        <td>Respiratory infections, MAC</td>
        <td>QT prolongation, GI upset</td>
        <td></td>
      </tr>
      <tr>
        <td>Minocycline</td>
        <td>Tetracyclines</td>
        <td>Acne, SIADH (demeclocycline)</td>
        <td>Photosensitivity, teeth staining</td>
        <td></td>
      </tr>
      <tr>
        <td>Demeclocycline</td>
        <td>Tetracyclines</td>
        <td>Acne, SIADH (demeclocycline)</td>
        <td>Photosensitivity, teeth staining</td>
        <td></td>
      </tr>
      <tr>
        <td>Tigecycline</td>
        <td>Glycylcycline</td>
        <td>Complicated infections (MRSA, VRE)</td>
        <td>GI upset, hepatotoxicity</td>
        <td></td>
      </tr>
      <tr>
        <td>Quinupristin/Dalfopristin</td>
        <td>Streptogramins</td>
        <td>VRE, resistant Gram+ cocci</td>
        <td>Myalgias, arthralgias</td>
        <td></td>
      </tr>
      <tr>
        <td>Linezolid</td>
        <td>Oxazolidinone</td>
        <td>MRSA, VRE</td>
        <td>Thrombocytopenia, serotonin syndrome</td>
        <td></td>
      </tr>
      <tr>
        <td>Chloramphenicol</td>
        <td>Protein synthesis inhibitor (50S)</td>
        <td>Rickettsia, meningitis backup</td>
        <td>Aplastic anemia, gray baby</td>
        <td></td>
      </tr>
      <tr>
        <td>Gentamicin</td>
        <td>Aminoglycoside</td>
        <td>Gram-negatives</td>
        <td>Nephrotoxicity, ototoxicity</td>
        <td></td>
      </tr>
      <tr>
        <td>Doxycycline</td>
        <td>Tetracycline</td>
        <td>Broad spectrum</td>
        <td>Photosensitivity</td>
        <td></td>
      </tr>
      <tr>
        <td>Azithromycin</td>
        <td>Macrolide</td>
        <td>Respiratory infections</td>
        <td>GI upset</td>
        <td></td>
      </tr>
      <tr>
        <td>Clindamycin</td>
        <td>Lincosamide</td>
        <td>Anaerobic infections</td>
        <td>C. difficile colitis</td>
        <td></td>
      </tr>
      <tr><td class="row-subdivider" colspan="5">DNA Inhibitors</td></tr>
      <tr>
        <td>Rifabutin</td>
        <td>Rifamycin</td>
        <td>MAC prophylaxis (HIV)</td>
        <td>Less CYP induction than rifampin</td>
        <td></td>
      </tr>
      <tr>
        <td>Nitrofurantoin</td>
        <td>DNA-damaging agent</td>
        <td>Uncomplicated UTIs</td>
        <td>Pulmonary fibrosis, GI upset</td>
        <td></td>
      </tr>
      <tr>
        <td>TMP-SMX</td>
        <td>Folate inhibitor combo</td>
        <td>UTIs, PCP pneumonia</td>
        <td>Hyperkalemia, sulfa allergy</td>
        <td></td>
      </tr>
      <tr><td class="row-subdivider" colspan="5">Antimycobacterial Agents</td></tr>
      <tr>
        <td>Isoniazid (INH)</td>
        <td>Mycolic acid synthesis inhibitor</td>
        <td>TB treatment</td>
        <td>Hepatotoxicity, neuropathy (B6 def)</td>
        <td></td>
      </tr>
      <tr>
        <td>Ethambutol</td>
        <td>Arabinogalactan synthesis inhibitor</td>
        <td>TB treatment</td>
        <td>Optic neuritis, red-green blindness</td>
        <td></td>
      </tr>
      <tr>
        <td>Clofazimine</td>
        <td>Unknown (leprosy agent)</td>
        <td>Multibacillary leprosy</td>
        <td>Skin discoloration</td>
        <td></td>
      </tr>
      <tr>
        <td>Streptomycin</td>
        <td>Aminoglycoside (30S)</td>
        <td>2nd line TB, plague</td>
        <td>Ototoxicity, nephrotoxicity</td>
        <td></td>
      </tr>
      <tr>
        <td>Ciprofloxacin</td>
        <td>Fluoroquinolone</td>
        <td>UTIs, GI infections</td>
        <td>Tendon rupture</td>
        <td></td>
      </tr>
      <tr>
        <td>Metronidazole</td>
        <td>Nitroimidazole</td>
        <td>Anaerobic infections</td>
        <td>Disulfiram-like reaction</td>
        <td></td>
      </tr>
      <tr>
        <td>Rifampin</td>
        <td>Rifamycin</td>
        <td>Tuberculosis</td>
        <td>Orange body fluids</td>
        <td></td>
      </tr>
      </tr>
    </tbody>
  </table>
</div>